These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3383470)

  • 1. Nisoldipine: a replacement therapy for nifedipine in the treatment of severe hypertension.
    Grossman E; Rosenthal T
    Clin Cardiol; 1988 May; 11(5):325-8. PubMed ID: 3383470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid development of tolerance to the antihypertensive effect of nisoldipine.
    Ramsay LE; Waller PC
    J Hum Hypertens; 1988 Mar; 1(4):277-80. PubMed ID: 3065506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nisoldipine and atenolol in the treatment of essential hypertension.
    Takahashi H; Fukuyama M; Yoneda S; Okabayashi H; Yoshimura M
    Arzneimittelforschung; 1989 Mar; 39(3):379-82. PubMed ID: 2667523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH
    J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age and efficacy of new long acting calcium blocker, nisoldipine, is essential hypertension].
    Kuwajima I; Kaneko Y; Takeda T
    Nihon Ronen Igakkai Zasshi; 1989 Jan; 26(1):37-46. PubMed ID: 2671449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of the calcium antagonist nisoldipine in hypertensive non-insulin-dependent diabetic patients.
    Odigwe CO; McCulloch AJ; Williams DO; Tunbridge WM
    Diabet Med; 1986; 3(5):463-7. PubMed ID: 2951198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypotensive effect of nisoldipine in renovascular hypertensive rats.
    Grossman E; Rosenthal T
    J Hypertens Suppl; 1986 Dec; 4(5):S141-4. PubMed ID: 3471895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine and nisoldipine in hypertensive diabetics.
    Clarke CW; Kubik MM
    J Hum Hypertens; 1991 Dec; 5(6):517-22. PubMed ID: 1791612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S139-48. PubMed ID: 2442506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study.
    Rosenfeld JB; Zabludowski J
    J Clin Pharmacol; 1989 Nov; 29(11):1013-6. PubMed ID: 2574728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
    Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
    Wambach G; Breuer G; Kaufmann W
    Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
    Kirch W; Stenzel J; Dylewicz P; Hutt HJ; Santos SR; Ohnhaus EE
    Br J Clin Pharmacol; 1986 Aug; 22(2):155-9. PubMed ID: 3530303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
    Archer SL; Yankovich RD; Chesler E; Weir EK
    J Pharmacol Exp Ther; 1985 Apr; 233(1):12-7. PubMed ID: 3872360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P; Lund-Johansen P; Haugland H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
    Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
    Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of spontaneous and glucocorticoid hypertension in rats by nisoldipine.
    Hall CE; Hungerford S
    Physiol Behav; 1983 Jun; 30(6):899-903. PubMed ID: 6351125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.